Innovative R&D
Koreidi (Nanjing) Pharmaceutical Technology Co., Ltd. was founded in October 2022 and is a subsidiary of Nanjing Entai Pharmaceutical Technology Co., Ltd. Conduct research and development of small molecule innovative drugs and improved new drugs with clinical value orientation and product thinking. The treatment areas include tumor adjuvant therapy, perioperative treatment, and drug-resistant bacterial infections.
- Pipeline name
- Indications in the field
- Preclinical
- IND
- Phase I clinical trial
- Phase II clinical trial
- Phase III clinical trial
- NDA
CR03
Neoadjuvant therapy
CR05
Anti-infection
CR06
Anti-infection
Address: 6th Floor, Building C6, Jiangsu Life Science and Technology Innovation Park, Qixia District, Nanjing City
Official account